GTS-21 dihydrochloride is a selective α7nAChR agonist with CAP anti‐inflammatory activities, which has been reported to alleviate acute lung injury [28] and cisplatin-induced nephropathy [29]. The gene discussed is CHRNA7; the disease is kidney disorder.